Suchergebnisse - "Langer-Gould, Annette"

PubPharm (10)

1

Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US : A Review

enthalten in: JAMA neurology | 2021

von Amezcua, L. | Rivera, V. | Vazquez, T. | +2

2

Environmental and genetic risk factors for MS : an integrated review

enthalten in: Annals of clinical and translational neurology | 2019

von Waubant, E. | Lucas, R. | Mowry, E. | +4

3

Pregnancy and Family Planning in Multiple Sclerosis

enthalten in: Continuum (Minneapolis, Minn.) | 2019

von Langer-Gould, A.

4

Vitamin D deficiency is an etiological factor for MS - No

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2019

von Langer-Gould, A. | Lucas, R.

5

A new way to estimate neurologic disease prevalence in the United States : Illustrated with MS

enthalten in: Neurology | 2019

von Nelson, L. | Wallin, M. | Marrie, R. | +10

6

Natalizumab use during the third trimester of pregnancy

enthalten in: JAMA neurology | 2014

von Haghikia, A. | Langer-Gould, A. | Rellensmann, G. | +12

7

Effects of pregnancy and breastfeeding on the multiple sclerosis disease course

enthalten in: Clinical immunology (Orlando, Fla.) | 2013

von Langer-Gould, A. | Beaber, B.

8

Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis : a systematic review

enthalten in: Archives of neurology | 2006

von Langer-Gould, A. | Popat, R. | Huang, S. | +4

CommentIn: Arch Neurol. 2007 Sep;64(9):1359; author reply 1359. - PMID 17846283

9

Progressive multifocal leukoencephalopathy and multiple sclerosis : lessons from natalizumab

enthalten in: Current neurology and neuroscience reports | 2006

von Langer-Gould, A. | Steinman, L.

10

Strategies for managing the side effects of treatments for multiple sclerosis

enthalten in: Neurology | 2004

von Langer-Gould, A. | Moses, H. | Murray, T.

1
[1]